Table S1. PCR primers and conditions used to define haplogroups (Hg) and *sub-haplogroups (Sub-Hg), and for PCR amplification of HVS-I and HVS-II regions (See ref. 4 and 5).
Table S2. Diagnostic restriction sites defining mtDNA haplogroups (Hg).
Table S3. Mitochondrial DNA diagnostic markers in HVS-I, HVS-II and in the coding region by which sub-haplogroups (Sub-Hg) are defined (MITOMAP:http://www.mitomap.org).
Table S4. Mitochondrial DNA (mtDNA)
sub-haplogroup (Sub-Hg) frequency distributions in patients with
FTD and controls. Absolute (N) and relative (%) frequencies with
standard errors (± SE) are shown. The asterisk denotes mtDNAs that were not classifiable within specific sub-haplogroups.
Table S5. Variant sites found in mitochondrial DNA HVS-I. For each haplotype, the absolute frequency in patients with sporadic frontotemporal dementia (FTD) (S), familial FTD (F) and controls (C) is reported. rCRS refers to revised Cambridge reference sequence (MITOMAP: http://www.mitomap.org, 2007). The position of the mutations is given according to rCRS less 16000. A total of 174 haplotypes were found, 24 of which were exclusive of familial FTD, 27 of sporadic FTD and 99 were exclusive of controls; the remaining eight haplotypes were shared between patients with FTD and controls.
Please note: Blackwell Publishing are not responsible for the content or functionality of any supplementary materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.
| Filename |
Description |
| ENE_2222_sm_table5.xls352 KB |
Supporting info item |
| ENE_2222_sm_tables1-4.doc160.5 KB |
Supporting info item |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
